This report aims to provide a comprehensive presentation of the global market for Antisense and RNAi Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antisense and RNAi Therapeutics. This report contains market size and forecasts of Antisense and RNAi Therapeutics in global, including the following market information:
Global Antisense and RNAi Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Antisense and RNAi Therapeutics market was valued at US$ 1321.4 million in 2022 and is projected to reach US$ 1893.4 million by 2029, at a CAGR of 5.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
RNA Interference Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Antisense and RNAi Therapeutics include Tekmira Pharmaceuticals, Arbutus Biopharma, Alnylam Pharmaceuticals, Antisense Therapeutics, Silence Therapeutics, Isis Pharmaceuticals, Sirnaomics, Santaris and Roche, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antisense and RNAi Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antisense and RNAi Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Antisense and RNAi Therapeutics Market Segment Percentages, by Type, 2022 (%)
- RNA Interference
- Antisense RNA
Global Antisense and RNAi Therapeutics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Antisense and RNAi Therapeutics Market Segment Percentages, by Application, 2022 (%)
- Hospital
- Clinic
Global Antisense and RNAi Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Antisense and RNAi Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- - US
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic Countries
- - Benelux
- - Rest of Europe
- Asia
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Rest of Asia
- South America
- - Brazil
- - Argentina
- - Rest of South America
- Middle East & Africa
- - Turkey
- - Israel
- - Saudi Arabia
- - UAE
- - Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antisense and RNAi Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Antisense and RNAi Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Tekmira Pharmaceuticals
- Arbutus Biopharma
- Alnylam Pharmaceuticals
- Antisense Therapeutics
- Silence Therapeutics
- Isis Pharmaceuticals
- Sirnaomics
- Santaris
- Roche
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antisense and RNAi Therapeutics, market overview.
Chapter 2: Global Antisense and RNAi Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Antisense and RNAi Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antisense and RNAi Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
Antisense and RNAi Therapeutics Market, Global Outlook and Forecast 2023-2029
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Antisense and RNAi Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antisense and RNAi Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antisense and RNAi Therapeutics Overall Market Size
2.1 Global Antisense and RNAi Therapeutics Market Size: 2022 VS 2029
2.2 Global Antisense and RNAi Therapeutics Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Antisense and RNAi Therapeutics Players in Global Market
3.2 Top Global Antisense and RNAi Therapeutics Companies Ranked by Revenue
3.3 Global Antisense and RNAi Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Antisense and RNAi Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Antisense and RNAi Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antisense and RNAi Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Antisense and RNAi Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Antisense and RNAi Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Antisense and RNAi Therapeutics Market Size Markets, 2022 & 2029
4.1.2 RNA Interference
4.1.3 Antisense RNA
4.2 By Type - Global Antisense and RNAi Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Antisense and RNAi Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Antisense and RNAi Therapeutics Revenue, 2024-2029
4.2.3 By Type - Global Antisense and RNAi Therapeutics Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Antisense and RNAi Therapeutics Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Antisense and RNAi Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Antisense and RNAi Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Antisense and RNAi Therapeutics Revenue, 2024-2029
5.2.3 By Application - Global Antisense and RNAi Therapeutics Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Antisense and RNAi Therapeutics Market Size, 2022 & 2029
6.2 By Region - Global Antisense and RNAi Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Antisense and RNAi Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Antisense and RNAi Therapeutics Revenue, 2024-2029
6.2.3 By Region - Global Antisense and RNAi Therapeutics Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Antisense and RNAi Therapeutics Revenue, 2018-2029
6.3.2 US Antisense and RNAi Therapeutics Market Size, 2018-2029
6.3.3 Canada Antisense and RNAi Therapeutics Market Size, 2018-2029
6.3.4 Mexico Antisense and RNAi Therapeutics Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Antisense and RNAi Therapeutics Revenue, 2018-2029
6.4.2 Germany Antisense and RNAi Therapeutics Market Size, 2018-2029
6.4.3 France Antisense and RNAi Therapeutics Market Size, 2018-2029
6.4.4 U.K. Antisense and RNAi Therapeutics Market Size, 2018-2029
6.4.5 Italy Antisense and RNAi Therapeutics Market Size, 2018-2029
6.4.6 Russia Antisense and RNAi Therapeutics Market Size, 2018-2029
6.4.7 Nordic Countries Antisense and RNAi Therapeutics Market Size, 2018-2029
6.4.8 Benelux Antisense and RNAi Therapeutics Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Antisense and RNAi Therapeutics Revenue, 2018-2029
6.5.2 China Antisense and RNAi Therapeutics Market Size, 2018-2029
6.5.3 Japan Antisense and RNAi Therapeutics Market Size, 2018-2029
6.5.4 South Korea Antisense and RNAi Therapeutics Market Size, 2018-2029
6.5.5 Southeast Asia Antisense and RNAi Therapeutics Market Size, 2018-2029
6.5.6 India Antisense and RNAi Therapeutics Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Antisense and RNAi Therapeutics Revenue, 2018-2029
6.6.2 Brazil Antisense and RNAi Therapeutics Market Size, 2018-2029
6.6.3 Argentina Antisense and RNAi Therapeutics Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Antisense and RNAi Therapeutics Revenue, 2018-2029
6.7.2 Turkey Antisense and RNAi Therapeutics Market Size, 2018-2029
6.7.3 Israel Antisense and RNAi Therapeutics Market Size, 2018-2029
6.7.4 Saudi Arabia Antisense and RNAi Therapeutics Market Size, 2018-2029
6.7.5 UAE Antisense and RNAi Therapeutics Market Size, 2018-2029
7 Antisense and RNAi Therapeutics Companies Profiles
7.1 Tekmira Pharmaceuticals
7.1.1 Tekmira Pharmaceuticals Company Summary
7.1.2 Tekmira Pharmaceuticals Business Overview
7.1.3 Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Major Product Offerings
7.1.4 Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Tekmira Pharmaceuticals Key News & Latest Developments
7.2 Arbutus Biopharma
7.2.1 Arbutus Biopharma Company Summary
7.2.2 Arbutus Biopharma Business Overview
7.2.3 Arbutus Biopharma Antisense and RNAi Therapeutics Major Product Offerings
7.2.4 Arbutus Biopharma Antisense and RNAi Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Arbutus Biopharma Key News & Latest Developments
7.3 Alnylam Pharmaceuticals
7.3.1 Alnylam Pharmaceuticals Company Summary
7.3.2 Alnylam Pharmaceuticals Business Overview
7.3.3 Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Major Product Offerings
7.3.4 Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Alnylam Pharmaceuticals Key News & Latest Developments
7.4 Antisense Therapeutics
7.4.1 Antisense Therapeutics Company Summary
7.4.2 Antisense Therapeutics Business Overview
7.4.3 Antisense Therapeutics Antisense and RNAi Therapeutics Major Product Offerings
7.4.4 Antisense Therapeutics Antisense and RNAi Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Antisense Therapeutics Key News & Latest Developments
7.5 Silence Therapeutics
7.5.1 Silence Therapeutics Company Summary
7.5.2 Silence Therapeutics Business Overview
7.5.3 Silence Therapeutics Antisense and RNAi Therapeutics Major Product Offerings
7.5.4 Silence Therapeutics Antisense and RNAi Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Silence Therapeutics Key News & Latest Developments
7.6 Isis Pharmaceuticals
7.6.1 Isis Pharmaceuticals Company Summary
7.6.2 Isis Pharmaceuticals Business Overview
7.6.3 Isis Pharmaceuticals Antisense and RNAi Therapeutics Major Product Offerings
7.6.4 Isis Pharmaceuticals Antisense and RNAi Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Isis Pharmaceuticals Key News & Latest Developments
7.7 Sirnaomics
7.7.1 Sirnaomics Company Summary
7.7.2 Sirnaomics Business Overview
7.7.3 Sirnaomics Antisense and RNAi Therapeutics Major Product Offerings
7.7.4 Sirnaomics Antisense and RNAi Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Sirnaomics Key News & Latest Developments
7.8 Santaris
7.8.1 Santaris Company Summary
7.8.2 Santaris Business Overview
7.8.3 Santaris Antisense and RNAi Therapeutics Major Product Offerings
7.8.4 Santaris Antisense and RNAi Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Santaris Key News & Latest Developments
7.9 Roche
7.9.1 Roche Company Summary
7.9.2 Roche Business Overview
7.9.3 Roche Antisense and RNAi Therapeutics Major Product Offerings
7.9.4 Roche Antisense and RNAi Therapeutics Revenue in Global Market (2018-2023)
7.9.5 Roche Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Antisense and RNAi Therapeutics Market Opportunities & Trends in Global Market
Table 2. Antisense and RNAi Therapeutics Market Drivers in Global Market
Table 3. Antisense and RNAi Therapeutics Market Restraints in Global Market
Table 4. Key Players of Antisense and RNAi Therapeutics in Global Market
Table 5. Top Antisense and RNAi Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Antisense and RNAi Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Antisense and RNAi Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Antisense and RNAi Therapeutics Product Type
Table 9. List of Global Tier 1 Antisense and RNAi Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antisense and RNAi Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type - Global Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Antisense and RNAi Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Antisense and RNAi Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application - Global Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Antisense and RNAi Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Antisense and RNAi Therapeutics Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region - Global Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Antisense and RNAi Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Antisense and RNAi Therapeutics Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2024-2029
Table 30. Tekmira Pharmaceuticals Company Summary
Table 31. Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Product Offerings
Table 32. Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Tekmira Pharmaceuticals Key News & Latest Developments
Table 34. Arbutus Biopharma Company Summary
Table 35. Arbutus Biopharma Antisense and RNAi Therapeutics Product Offerings
Table 36. Arbutus Biopharma Antisense and RNAi Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Arbutus Biopharma Key News & Latest Developments
Table 38. Alnylam Pharmaceuticals Company Summary
Table 39. Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Product Offerings
Table 40. Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Alnylam Pharmaceuticals Key News & Latest Developments
Table 42. Antisense Therapeutics Company Summary
Table 43. Antisense Therapeutics Antisense and RNAi Therapeutics Product Offerings
Table 44. Antisense Therapeutics Antisense and RNAi Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Antisense Therapeutics Key News & Latest Developments
Table 46. Silence Therapeutics Company Summary
Table 47. Silence Therapeutics Antisense and RNAi Therapeutics Product Offerings
Table 48. Silence Therapeutics Antisense and RNAi Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Silence Therapeutics Key News & Latest Developments
Table 50. Isis Pharmaceuticals Company Summary
Table 51. Isis Pharmaceuticals Antisense and RNAi Therapeutics Product Offerings
Table 52. Isis Pharmaceuticals Antisense and RNAi Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. Isis Pharmaceuticals Key News & Latest Developments
Table 54. Sirnaomics Company Summary
Table 55. Sirnaomics Antisense and RNAi Therapeutics Product Offerings
Table 56. Sirnaomics Antisense and RNAi Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. Sirnaomics Key News & Latest Developments
Table 58. Santaris Company Summary
Table 59. Santaris Antisense and RNAi Therapeutics Product Offerings
Table 60. Santaris Antisense and RNAi Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. Santaris Key News & Latest Developments
Table 62. Roche Company Summary
Table 63. Roche Antisense and RNAi Therapeutics Product Offerings
Table 64. Roche Antisense and RNAi Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 65. Roche Key News & Latest Developments
List of Figures
Figure 1. Antisense and RNAi Therapeutics Segment by Type in 2022
Figure 2. Antisense and RNAi Therapeutics Segment by Application in 2022
Figure 3. Global Antisense and RNAi Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Antisense and RNAi Therapeutics Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Antisense and RNAi Therapeutics Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antisense and RNAi Therapeutics Revenue in 2022
Figure 8. By Type - Global Antisense and RNAi Therapeutics Revenue Market Share, 2018-2029
Figure 9. By Application - Global Antisense and RNAi Therapeutics Revenue Market Share, 2018-2029
Figure 10. By Type - Global Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Antisense and RNAi Therapeutics Revenue Market Share, 2018-2029
Figure 12. By Application - Global Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Antisense and RNAi Therapeutics Revenue Market Share, 2018-2029
Figure 14. By Region - Global Antisense and RNAi Therapeutics Revenue Market Share, 2018-2029
Figure 15. By Country - North America Antisense and RNAi Therapeutics Revenue Market Share, 2018-2029
Figure 16. US Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Antisense and RNAi Therapeutics Revenue Market Share, 2018-2029
Figure 20. Germany Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 21. France Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Antisense and RNAi Therapeutics Revenue Market Share, 2018-2029
Figure 28. China Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 32. India Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Antisense and RNAi Therapeutics Revenue Market Share, 2018-2029
Figure 34. Brazil Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Antisense and RNAi Therapeutics Revenue Market Share, 2018-2029
Figure 37. Turkey Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2018-2029
Figure 41. Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Arbutus Biopharma Antisense and RNAi Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Antisense Therapeutics Antisense and RNAi Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Silence Therapeutics Antisense and RNAi Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Isis Pharmaceuticals Antisense and RNAi Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Sirnaomics Antisense and RNAi Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Santaris Antisense and RNAi Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Roche Antisense and RNAi Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Global Targeted RNA Sequencing Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 71
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing The ability to detect both known and novel gene fusion partners in many sample types.
In The report, we ......
Global Targeted RNA Sequencing Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 87
According to our LPI (LP Information) latest study, the global Targeted RNA Sequencing market size was valued at US$ 1761.4 million in 2023. With growing demand in downstream market, the Targeted RNA Sequencing is forecast to a readjusted size of US$ 7649.2 million by 2030 with a CAGR of 23.3% during review period.
The research report highlights the growth potential of the global Targeted RNA Sequencing market. Targeted RNA Sequencing are expected to show stable growth in the future mark......
Global Targeted RNA Sequencing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 94
According to our (Global Info Research) latest study, the global Targeted RNA Sequencing market size was valued at USD 1852.7 million in 2023 and is forecast to a readjusted size of USD 7255.4 million by 2030 with a CAGR of 21.5% during review period.
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or ......
Global Antisense and RNAi Therapeutics Market Research Report 2023, Forecast to 2028
Published: 26-Dec-2023 Price: US 2680 Onwards Pages: 133
Antisense therapy means the selective, sequence-specific inhibition of gene expression by single-stranded DNA oligonucleotides. In contrast, RNA interference (RNAi) is triggered by double-stranded RNA (dsRNA) and causes sequence-specific mRNA degradation of single-stranded target RNAs in response to dsRNA.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (millio......
Global Antisense and RNAi Therapeutics Professional Survey Report 2023, Forecast to 2028
Published: 26-Dec-2023 Price: US 3280 Onwards Pages: 101
Antisense therapy means the selective, sequence-specific inhibition of gene expression by single-stranded DNA oligonucleotides. In contrast, RNA interference (RNAi) is triggered by double-stranded RNA (dsRNA) and causes sequence-specific mRNA degradation of single-stranded target RNAs in response to dsRNA.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (millio......
Global Targeted RNA Sequencing Market Research Report 2023, Forecast to 2028
Published: 13-Nov-2023 Price: US 2680 Onwards Pages: 137
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......
Global Targeted RNA Sequencing Professional Survey Report 2023, Forecast to 2028
Published: 13-Nov-2023 Price: US 3280 Onwards Pages: 100
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......
Global RNAi for Therapeutic Market Status and Outlook 2023-2028
Published: 08-Nov-2023 Price: US 3160 Onwards Pages: 106
RNAi is a fundamental cellular mechanism for silencing gene expression that can be harnessed for the development of new drugs
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......
Global RNAi for Therapeutic Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 24-Oct-2023 Price: US 3380 Onwards Pages: 104
Market Overview of Global RNAi for Therapeutic market:
According to our latest research, the global RNAi for Therapeutic market looks promising in the next 5 years. As of 2022, the global RNAi for Therapeutic market was estimated at USD 260.55 million, and it's anticipated to reach USD 3633.33 million in 2028, with a CAGR of 55.14% during the forecast years.
RNA interference (RNAi) is a collection of small RNA directed mechanisms that result in sequence specific inhibition of......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
